WRITER | EDITOR | STORYTELLER

BioSpace, based in Des Moines, Iowa, publishes news articles related to the pharmaceutical, biotech and life sciences industries. Links to selected stories published on BioSpace are below. A complete list of work for BioSpace can be found here.


While working at BioSpace I have had the opportunity to interview a number of C-Suite level executives about a variety of topics related to the future of the pharma and biotech companies. Below are a select few articles.


Two Biotech CEOs Charged in Securities Fraud Schemes Dec. 21, 2022
​The U.S. Department of Justice indicted former CytoDyn Inc. CEO Nader Z. Pourhassan and the CEO of Amarex Clinical Research on multiple counts of fraud.

AbbVie is Enabling Students Diagnosed with Immunological Diseases to Shine June 1, 2022

The AbbVie Immunology Scholarship provides financial support to students living with chronic, immune-mediated diseases who are pursuing higher education in the United States.

Ex-Theranos CEO Elizabeth Holmes Convicted of Fraud, Sentenced to 11 Years Nov. 18, 2022

Former Theranos CEO Elizabeth Holmes will serve 11 years in prison on four counts of fraud, according to her sentencing by a federal judge in a California courtroom on Friday afternoon.


Gilmore O’Neill “Excited” to Take the Reins at Editas Medicine April 14, 2022

For some time, Gilmore O’Neill had been searching for the opportunity to take on a chief executive officer role and guide the fortunes of a pharmaceutical or biotech company. Several opportunities came his way but only one really jumped off the pages – the chance to take over Editas Medicine.


Under Fire From Investors, Walmsley Outlines Vision for GSK June 23, 2021

Calling herself a “change agent,” GlaxoSmithKline Chief Executive Officer Emma Walmsley outlined plans to transform the pharmaceuticals business of her company following the expected spin-off of the company’s consumer health division during an investor conference.


Sanofi Executives Predict 2021 Will be ‘Transformative’ Year for Company Jan. 8, 2021

With eight drugs awaiting regulatory approval and 26 projects in Phase III studies, Sanofi is on the cusp of a transformative year during 2021. That was the message the company shared during a pre-J.P. Morgan Healthcare conference roundtable discussion with BioSpace and other journalists. Frank Nestle, Sanofi’s chief scientific officer and Global Head of Research, and Dietmar Berger, Sanofi’s chief medical officer and Global Head of Development, provided an overview of the company’s clinical activities and highlighted some of the assets that will be key revenue drives for the company.


Powerful U.S. Political and Business Leaders Lost Hundreds of Millions on Theranos May 7, 2018

Failed blood-testing developer Theranos was known for its high-profile supporters who had tremendous business and political clout. Names like Rupert Murdoch, Betsy Devos and James Baker were known investors in the company.


Notorious Turing CEO Martin Shkreli Arrested for Securities Fraud Dec. 17, 2015

NEW YORK – Martin Shkreli, the pharmaceutical industry’s so-called “bad boy,” has been arrested on charges of securities fraud related to his tenure as chief executive officer of Retrophin Inc. (RTRX).


Alnylam’s John Maraganore Leads RNAi Development With a Bold Vision  April 1, 2016

CAMBRIDGE, Mass. – Alnylam Pharmaceuticals (ALNY) is led by a chief executive with a bold vision to use RNA interference (RNAi) to develop therapies that will lead to the end of rare diseases, such as Transthyretin-related hereditary (TTR) amyloidosis and various disorders of the blood.


Evelo and Epiva Biosciences Merge to Become a Leading Immuno-Microbiome Platform Company  July 13, 2016

CAMBRIDGE, Mass. – Less than a year after it exited stealth mode, startup Evelo BioSciences has found a kindred spirit in another Flagship Ventures company, Epiva Biosciences. The two companies, both developing microbiome therapies, will combine efforts in a new company to become the leading immuno-microbiome platform company in the U.S.


Startup Bioz Launches With First Search Engine Built for Life Science Research July 20, 2016

PALO ALTO, Calif. – If you’re a scientific researcher a huge chunk of your time is taken up by plowing through countless articles to determine how to structure your research. That process takes a long time. Until now, there had not been a better way.

That’s where Bay Area-based Bioz comes in. The new software startup has unveiled an industry-first search engine built exclusively for the life sciences industry.


Theranos CEO Elizabeth Holmes Banned from Operating a Lab for Two Years July 8, 2016

PALO ALTO, Calif. – The hammer has fallen. Elizabeth Holmes, the embattled chief executive officer of blood testing company Theranos, will not be allowed to own or operate a blood testing laboratory for two years, the company announced on its website Thursday afternoon.